Presentation

Poster

  • 7.     C. A. Swindlehurst, L. F. Kyle, W. H. Chan, S. Ottilie, A. Shahbandi, C. L. Morris, O. L Francis, S. Martinez, T. Bennett, and K. J. Payne “Two New Classes of Drugs to Target Chemo-Resistant and High Risk B-ALL”, 53rdAnnual American Society of Hematology Meeting and Exposition, San Diego, CA 2011 (12/2011)
  • 6.     O.L. Francis, S.R. Martinez, T. Bennett, I. Baez, T. Milford, C. L. Morris, R. O. Fisher, X. Zhang, R. Su, S. Dovat and K. J. Payne A Novel Pre-Clinical Model to Identify Therapies for CRLF2 B-ALL and Reduce Childhood Cancer Health Disparities, 5thAmerican Association for Cancer Research Conference on ‘The Science of Cancer Health Disparities’, San Diego, CA October, 2012 (10/2012)
  • 5.     K.J. Payne, O.L. Francis, T. Milford, S. Martinez, I. Baez, A.J. Weldon, R. Johnson, S. Montgomery, R. Fisher, C.L. Morris, X. Zhang, S. Dovat, and R. Su. “The effect of TSLP on normal B cell progenitors and CRLF2 B-ALL in a human-mouse xenograft model." Annual American Society of Pediatric Hematology/Oncology Meeting, Miami, FL, April 2013.  (04/2013)
  • 4.     O.L. Francis, R. Sun, S. Martinez, I. Baez, T. Milford, R. Fisher, C.L. Morris, X. Zhang, V. Filippov, S. Dovat and K.J. Payne “TSLP up-regulates expression of genes involved in cell survival in a preclinical xenograft model of CRLF2 B-ALL.” 105th Annual American Association for Cancer Research Meeting, San Diego, CA April, 2014  (04/2014)
  • 3.     O.L. Francis, T. Milford, I. Baez, J. Coats, C.L. Morris, R. Fisher, B.J. Van Handel, R. Su, B. Suterwala, S. Farzingohar, S Dovat, K.J. Payne. A Patient-Derived Xenograft Model for Identifying Therapies and Defining Mechanisms of TSLP-Induced CRLF2 Signals in Ph-like B-ALL, , American Society of Hematology, Orlando, FL December, 2015 (12/2015)
  • 2.     C. Stoian, M.O. Kamal, O.L. Francis,R. Johnson, S. Montgomery, J.S. Coats, H. Choi, S Aponte-Paris, M. Reed, S.R. Martinez, K. Mayagoitia, E. Chirshev, S. Dovat, K.J. Payne. TSLP regulates expression of Bcl2 family proteins in Ph-like ALL with CRLF2 alterations. 107thAnnual American Association for Cancer Research, New Orleans, LA 2016 (03/2016)
  • 1.     Kaythryn Rager, Amara Hendricks, David Yi Xu,Huynh Cao, David Baylink, Kimberly J Payne, Olivia L. Francis-Boyle “Characterization of Human Tumor Infiltrating Lymphocytes and Human Acute Myeloid Leukemia Cells for use in an AML Patient Derived Xenograft Mouse Model”, Annual Post-Graduate Convention, Loma Linda, CA March 2021   (03/2021)

Research

  • O. L. Francis, The Impact of Notch on Normal & Malignant Myelopoiesis. Faculty of Graduate Studies Research Seminar, Loma Linda University, Nov., 2017, Loma Linda, CA (11/2017)
  • O. L. Francis, The Impact of Notch on Normal & Malignant Myelopoiesis. Cancer Research In Progress Seminar, Loma Linda University, Mar. 7th, 2018, Loma Linda, CA (03/2018)
  • O. L. Francis-Boyle, "Evaluation of Promising Therapuetic Candidates for the Treatment of Myeloid Leukemia". Cancer Research In Progress Seminar, Loma Linda University, Oct 6th, 2021, Loma Linda, CA (10/2021)
  • P. Shiraz, O. L. Francis, I. Baez, K. Sacedo-Concepcion, K. Mayagoitia, E. Ginelli, T. Milford, J. Coats, R. Fisher, C.L. Morris, X. Zhang, R. Su, K.J. Payne.  A Preclinical Xenograft Model to Identify Disease Mechanisms and Therapies for CRLF2 B-cell Acute Lymphoblastic Leukemia. American Federation for Medical Research 2015 (Western Regional Meeting), Carmel, CA (01/2015)